Isavuconazonium (Cresemba)

SELF-ADMINISTRATION - ORAL

OFFICE-ADMINISTRATION - IV INJECTION

FDA Approved Indications:
  • Treatment of invasive aspergillosis
  • Treatment of invasive mucormycosis
Prior authorization criteria:
  • Prescribed by or in collaboration with a specialist, AND
  • Patient is 18 years of age or older, AND
  • Patient is being treated for invasive aspergillosis or invasive mucormycosis, AND
  • Patient has tried and failed or is unable to take voriconazole, AND
  • Patient is not taking a strong CYP3A4 inhibitor or strong CYP3A4 inducer concomitantly with Cresemba, AND
  • Cresemba is contraindicated in patients with familial short QT syndrome
  • Use with caution in patients with severe liver impairment (Child-Pugh class C), and liver function tests should be monitored
Dosing:
  • Loading Dose: 372 mg isavuconazonium sulfate (equivalent to 200 mg of isavuconazole) every 8 hours for 6 doses (48 hours) via oral (2 capsules) or IV administration (1 reconstituted vial)
  • Maintenance Dose: 372 mg isavuconazonium sulfate (equivalent to 200 mg of isavuconazole) once daily via oral (2 capsules) or IV administration (1 reconstituted vial) starting 12 to 24 hours after the last loading dose
  • Switching between the IV and oral formulations of Cresemba is acceptable as bioequivalence has been demonstrated.  Loading dose in not required when swithcing between formulations.
Approval:
  • 12 weeks

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.

Press Esc to cancel

El sitio Web al que está siendo transferido no es provisto por WHA. Las Condiciones de Uso y las Prácticas de Privacidad en Internet de WHA no se aplican a este sitio Web asociado que usted está usando. Revise las políticas sobre la privacidad y condiciones de uso de este sitio Web asociado. WHA no tiene control sobre la exactitud, la totalidad o la actualidad del contenido del sitio Web asociado. WHA no puede garantizar que los servicios de traducción de idiomas estarán disponibles en el sitio vinculado.

Presione «Esc» para cancelar